Search Results - "Cubero, Javier Segovia"

Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis by Moñivas Palomero, Vanessa, Durante-Lopez, Alejandro, Sanabria, Mario Torres, Cubero, Javier Segovia, González-Mirelis, Jesús, Lopez-Ibor, Jorge Vazquez, Navarro Rico, Sara M., Krsnik, Isabel, Dominguez, Fernando, Mingo, Alejandro Martinez, Hernandez-Perez, Francisco J., Cavero, Gibanel, Santos, Susana Mingo

“…Cardiac amyloidosis (CA) causes restrictive cardiomyopathy usually associated with a poor prognosis. Two subtypes predominate: systemic light-chain CA (ALCA)…”
Get full text

Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry by Alonso-Gonzalez, Rafael, Lopez-Guarch, Carmen Jiménez, Subirana-Domenech, Maria Teresa, Ruíz, José María Oliver, González, Isabel Otero, Cubero, Javier Segovia, del Cerro, Maria Jesus, Salvador, Maria Lázaro, Subira, Laura Dos, Gallego, Pastora, Escribano-Subias, Pilar

“…Abstract Background Pulmonary arterial hypertension (PAH) is common in patients with congenital heart disease (CHD). Although Eisenmenger syndrome may be on…”
Get full text

Endomyocardial biopsy using the brachial venous access route. Description of the technique and 12-year experience at 2 different centers by Tamargo, María, Gutiérrez Ibañes, Enrique, Oteo Domínguez, Juan Francisco, Díez-Delhoyo, Felipe, León Aliz, Ebrey, Sanz Ruiz, Ricardo, Hernández Pérez, Francisco José, Vázquez Álvarez, María Eugenia, Segovia Cubero, Javier, Rivera Juárez, Allan, Zataraín, Eduardo, Goicolea Ruigómez, Javier, Soriano, Javier, Pérez Pereira, Elena, García-Carreño, Jorge, García Touchard, Arturo, Grigorian, Lilian, Fernández Díaz, José Antonio, Elízaga, Jaime, Alonso Pulpón, Luis, Fernández-Avilés, Francisco

“…ABSTRACT Introduction and objectives: Recipients of a heart transplant need to receive serial endomyocardial biopsies (EMB) to discard rejection, a procedure…”
Get full text

Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION‐HEART multicentre randomised trial by Comín‐Colet, Josep, Manito, Nicolás, Segovia‐Cubero, Javier, Delgado, Juan, García Pinilla, José Manuel, Almenar, Luis, Crespo‐Leiro, María G., Sionis, Alessandro, Blasco, Teresa, Pascual‐Figal, Domingo, Gonzalez‐Vilchez, Francisco, Lambert‐Rodríguez, José Luis, Grau, María, Bruguera, Jordi

“…Aims The LION‐HEART study was a multicentre, double‐blind, randomised, parallel‐group, placebo‐controlled trial evaluating the efficacy and safety of…”
Get full text

Outcomes of percutaneous coronary intervention of chronic total occlusions in heart transplant recipients by Solano-López Morel, Jorge, Fernández-Díaz, José A., MartIn Yuste, Victoria, Sabaté Tenas, Manel, Oteo-Domínguez, Juan F., García-Touchard, Arturo, Estévez Loureiro, Rodrigo, Segovia Cubero, Javier, Hernández Pérez, Francisco José, Blasco Lobo, Ana, Alonso-Pulpón, and, Luis, Goicolea-Ruigómez, Javier

“…ABSTRACT Introduction and objectives: Chronic total coronary occlusion (CTO) of coronary arteries is frequent in heart transplant recipients (HTR). It is…”
Get full text

Diagnostic yield and safety profile of endomyocardial biopsy in the non-transplant setting at a Spanish referral center by García-Izquierdo Jaén, Eusebio, Oteo Domínguez, Juan Francisco, Jiménez Blanco, Marta, Aguilera Agudo, Cristina, Domínguez, Fernando, Toquero Ramos, Jorge, Segovia Cubero, Javier, Salas Antón, Clara, García-Touchard, Arturo, Fernández-Díaz, José Antonio, Estévez-Loureiro, Rodrigo, Ruigómez, and, Francisco Javier Goicolea, Alonso-Pulpón, Luis

“…ABSTRACT Introduction and objectives: Endomyocardial biopsy (EMB) is an established diagnostic tool in myocardial disease. However, this technique may carry…”
Get full text

Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry by Barge‐Caballero, Eduardo, Almenar‐Bonet, Luis, Gonzalez‐Vilchez, Francisco, Lambert‐Rodríguez, José L., González‐Costello, José, Segovia‐Cubero, Javier, Castel‐Lavilla, María A., Delgado‐Jiménez, Juan, Garrido‐Bravo, Iris P., Rangel‐Sousa, Diego, Martínez‐Sellés, Manuel, Fuente‐Galan, Luis, Rábago‐Juan‐Aracil, Gregorio, Sanz‐Julve, Marisa, Hervás‐Sotomayor, Daniela, Mirabet‐Pérez, Sonia, Muñiz, Javier, Crespo‐Leiro, Maria G.

“…Background In Spain, listing for high‐urgent heart transplantation is allowed for critically ill candidates not weanable from temporary mechanical circulatory…”
Get full text

Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: The international BRIGHT study by Denhaerynck, Kris, Berben, Lut, Dobbels, Fabienne, Russell, Cynthia L., Crespo‐Leiro, Marisa G., Poncelet, Alain Jean, De Geest, Sabina, Crespo‐Leiro, Maria G., Cupples, Sandra, De Simone, Paolo, Groenewoud, Albert, Kugler, Christiane, Ohler, Linda, Van Cleemput, Johan, Sebbag, Laurent, Michel, Magali, Bernard, Andrée, Doesch, Andreas, Livi, Ugolino, Manfredini, Valentina, Brossa‐Loidi, Vicens, Segovia‐Cubero, Javier, Almenar‐Bonet, Luis, Saint‐Gerons, Carmen Segura, Mohacsi, Paul, Horvath, Eva, Riotto, Cheryl, Parry, Gareth, Firouzi, Ashi, Kozuszko, Stella, Haddad, Haissam, Kaan, Annemarie, Fisher, Grant, Miller, Tara, Flattery, Maureen, Ludrosky, Kristin, Coleman, Bernice, Trammell, Jacqueline, St. Clair, Katherine, Kao, Andrew, Molina, Maria, Canales, Karyn Ryan, Almeida, Samira Scalso, Ayoub, Andrea Cotait, Barone, Fernanda, Harkess, Michelle, Maddicks‐Law, Joanne

“…Factors at the level of family/healthcare worker, organization, and system are neglected in medication nonadherence research in heart transplantation (HTx)…”
Get full text

β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE‐HF): a double blind, placebo‐controlled, randomized clinical trial by García‐Álvarez, Ana, Blanco, Isabel, García‐Lunar, Inés, Jordà, Paloma, Rodriguez‐Arias, Juan J., Fernández‐Friera, Leticia, Zegri, Isabel, Nuche, Jorge, Gomez‐Bueno, Manuel, Prat, Susanna, Pujadas, Sandra, Sole‐Gonzalez, Eduard, Garcia‐Cossio, Maria D., Rivas, Mercedes, Torrecilla, Estefanía, Pereda, Daniel, Sanchez, Javier, García‐Pavía, Pablo, Segovia‐Cubero, Javier, Delgado, Juan F, Mirabet, Sonia, Fuster, Valentín, Barberá, Joan A., Ibañez, Borja

“…Aims Pulmonary hypertension (PH) associated with left heart disease is an increasingly prevalent problem, orphan of targeted therapies, and related to a poor…”
Get full text

Prevalence and characterization of frailty, depression, and cognitive impairment in patients listed for heart transplantation: Results of the FELICITAR prospective registry by Ayesta, Ana, Valero Masa, María Jesús, Vidán, María Teresa, Luna‐López, Raquel, Segovia‐Cubero, Javier, García‐Cosío, María Dolores, Pérez Gómez, Laura, Pérez, Pedro Caravaca, Vázquez López‐ Ibor, Jorge, Nuche, Jorge, Martínez‐Sellés, Manuel

“…Introduction It is recommended to assess frailty prior to heart transplantation (HT). Our objective was to assess the prevalence of frailty in patients listed…”
Get full text

Management and prognosis of HIV‐associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry by Salvador, María Lázaro, Rodríguez‐Padial, Luis, Soto Abánades, Clara, Cruz Utrilla, Alejandro, Barberá Mir, Joan Albert, López‐Meseguer, Manuel, Segovia Cubero, Javier, Samper, Gustavo Juan, Blanco Vich, Isabel, Escribano‐Subías, Pilar

“…Background Pulmonary arterial hypertension (PAH) is an independent predictor of death in patients with human immunodeficiency virus (HIV) infection. HIV is the…”
Get full text

External validation and comparison of the CardShock and IABP-SHOCK II risk scores in real-world cardiogenic shock patients by Rivas-Lasarte, Mercedes, Sans-Roselló, Jordi, Collado-Lledó, Elena, González-Fernández, Víctor, Noriega, Francisco J, Hernández-Pérez, Francisco J, Fernández-Martínez, Juan, Ariza, Albert, Lidón, Rosa-Maria, Viana-Tejedor, Ana, Segovia-Cubero, Javier, Harjola, Veli-Pekka, Lassus, Johan, Thiele, Holger, Sionis, Alessandro

“…Mortality from cardiogenic shock remains high and early recognition and risk stratification are mandatory for optimal patient allocation and to guide treatment…”
Get full text

AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor by Ríos-Tamayo, Rafael, Krsnik, Isabel, Gómez-Bueno, Manuel, Garcia-Pavia, Pablo, Segovia-Cubero, Javier, Huerta, Ana, Salas, Clara, Silvestre, Ramona Ángeles, Sánchez, Amelia, Manso, Marta, Delgado, Laura, Lahuerta, Juan José, Martínez-López, Joaquín, Duarte, Rafael F

“…Monoclonal gammopathies (MGs) are a wide range of diseases that may evolve or progress over time. Comorbidity plays a critical role in this setting. The…”
Get full text

Clinical picture, management and risk stratification in patients with cardiogenic shock: does gender matter? by Collado-Lledó, Elena, Llaó, Isaac, Rivas-Lasarte, Mercedes, González-Fernández, Victor, Noriega, Francisco J, Hernández-Perez, Francisco José, Alegre, Oriol, Sionis, Alessandro, Lidón, Rosa M, Viana-Tejedor, Ana, Segovia-Cubero, Javier, Ariza-Solé, Albert

“…Abstract Background Early recognition and risk stratification are crucial in cardiogenic shock (CS). A lower adherence to recommendations has been described in…”
Get full text

Use of Idarucizumab to reverse the anticoagulant effect of dabigatran in cardiac transplant surgery. A multicentric experience in Spain by Crespo‐Leiro, Maria G., López‐Vilella, Raquel, López Granados, Amador, Mirabet‐Pérez, Sonia, Díez‐López, Carles, Barge‐Caballero, Eduardo, Segovia‐Cubero, Javier, González‐Vilchez, Francisco, Rangel‐Sousa, Diego, Blasco‐Peiró, Teresa, Fuente‐Galán, Luis, Díaz‐Molina, Beatriz, Zatarain‐Nicolás, Eduardo, Carrasco Ávalos, Francisco, Almenar‐Bonet, Luis

“…Background Anticoagulation in heart transplant (HT) recipients increases the risk of hemorrhagic complications, so correct reversal of anticoagulation is…”
Get full text

Danon Disease Presenting as Eosinophilic Myocarditis by Angulo-Lara, Basilio, Garrido-González, Ramón, Salas Antón, Clara, Oteo-Domínguez, Juan Francisco, Segovia-Cubero, Javier, Domínguez, Fernando

“…A 21-year-old woman with a history of atopy, peripheral eosinophilia, Wolf-Parkinson-White syndrome, and 5 episodes of myocarditis was diagnosed with…”
Get full text

Checkpoint inhibitor-induced fulminant myocarditis, complete atrioventricular block and myasthenia gravis—a case report by Portolés Hernández, Antonio, Blanco Clemente, Mariola, Escribano García, Daniel, Velasco Calvo, Rocío, Núñez García, Beatriz, Oteo Domínguez, Juan Francisco, Salas Antón, Clara, Méndez García, Miriam, Segovia Cubero, Javier, Domínguez, Fernando

“…Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy over the last decade. Pembrolizumab, a humanized monoclonal IgG4 antibody, binds to the…”
Get full text

The cardiomyopathy of cystic fibrosis: a modern form of Keshan disease by Segovia-Cubero, Javier, Ruiz-Bautista, Lorena, Maiz-Carro, Luis, Girón-Moreno, Rosa M, Prados-Sánchez, M Concepción, Martínez-Martínez, M Teresa, González-Estecha, Montserrat, Mingo-Santos, Susana, Gómez-Bueno, Manuel, Salas-Antón, Clara, Cavero-Gibanel, Miguel A, Pastrana-Ledesma, Miguel, García-Pavía, Pablo, Laporta-Hernández, Rosalía, Sánchez-Ortiz, David, Alonso-Pulpón, Luis

“…We conducted a study to determine the prevalence of structural heart disease in patients with CF, the characteristics of a cardiomyopathy not previously…”
Get full text

Gender Differences in Cardiogenic Shock Patients: Clinical Features, Risk Prediction, and Outcomes in a Hub Center by Lozano-Jiménez, Sara, Iranzo-Valero, Reyes, Segovia-Cubero, Javier, Gómez-Bueno, Manuel, Rivas-Lasarte, Mercedes, Mitroi, Cristina, Escudier-Villa, Juan Manuel, Oteo-Dominguez, Juan Francisco, Vieitez-Florez, Jose María, Villar-García, Susana, Hernández-Pérez, Francisco José

“…There is scarce knowledge about gender differences in clinical presentation, management, use of risk stratification tools and prognosis in cardiogenic shock…”
Get full text

Lack of Usefulness of Donor-Derived Cell-Free DNA as a Biomarker for Cardiac Allograft Vasculopathy: A Prospective Study by Jiménez-Blanco Bravo, Marta, Pérez-Gómez, Laura, Hernández-Pérez, Francisco J, Arellano-Serrano, Carlos, Torres-Sanabria, Mario, Gómez-Bueno, Manuel, Oteo-Domínguez, Juan F, Mingo-Santos, Susana, Segovia-Cubero, Javier

“…Cardiac allograft vasculopathy (CAV) remains a major cause of morbidity and mortality among long-term heart transplant recipients. There is an unmet need for a…”
Get full text